Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TFX · against 454 other Healthcare companies listed in US-listed
Ranked #330 of 455 · scores higher than 27% of peers
Bars: peers in each 10-point band of the growth score32 peers with a growth score of 30–39, including TFX · Click a bar to see the companies
Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
| Metric | TFX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 17.2% | 11.0% | 62% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | -10.6% | 11.0% | 11% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 328 | 8.5B USD | 37 | 28 | |
| 330 | 3.0B USD | 36 | 35 | |
| 330 | 38.9B USD | 36 | 56 | |
| 330 | 2.6B USD | 36 | 32 | |
| 330 | 5.9B USD | 36 | 39 | |
| 334 | 256M USD | 35 | 80 | |
| 334 | 2.0B USD | 35 | 27 | |
| 334 | 27M USD | 35 | 24 | |
| 337 | 2.5B USD | 34 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score